various. (2003). Livre des communications = Libro de ponencias. In Clat2 : 2e conférence latine de risques liés aux usages de drogues = Clat2 : 2a conferencia latina reducción de daños relacionados con los usos de las drogas (117). Perpignan: Association française pour la réduction des risques (AFR); Ascode; Grup Igia.
|
Observatoire européen des drogues et des toxicomanies, & Commission interaméricaine de lutte contre l'abus des drogues de l'Organisation des États américains (Eds.). (2010). Création d'un observatoire national des drogues : manuel conjoint. Joint publications. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Office of National Drug Control Policy. (2010). National drug control strategy 2010 (Office of National Drug Control Policy, Ed.). Washington: Executive Office of the President of the United States.
Keywords: prevention; treatment and maintenance; law enforcement; government and politics; AOD public policy strategy; public policy on AOD; public policy on illicit drugs; addiction; AOD use, abuse, and dependence; AODR crime; drug dealing; drug trafficking; illegal production of drugs; illicit drug industry; drug market; prevention through education; adolescent; cooperation; United States; international area
|
Observatoire européen des drogues et des toxicomanies. (2011). Rapport annuel 2011 : état du phénomène de la drogue en Europe. Rapport annuel. Luxembourg: Office des publications de l'Union européenne.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; mephedrone; Europe; annual report
|
Spapen, P., Angelidis, T., Antoniali, V., Van Gerwen, K., Pelc, I., & Verbanck, P. (2010). La thérapie familiale multidimensionnelle des adolescent(e)s dépendants du cannabis : une nouvelle approche systémique en Europe dans le cadre d'une recherche plurinationale. Thérapie familiale, 30(2), 117–132.
Abstract: Certains adolescents consommateurs de cannabis présentent une réelle assuétude qui s’accompagne le plus souvent d’une série d’autres difficultés personnelles, familiales et sociales. Un modèle intégratif de thérapie familiale adapté à cette problématique et basé sur les données de la recherche est présenté et illustré par une situation clinique. Some adolescent cannabis users develop a real addiction which is often associated with different individual, familial and social difficulties. An integrative research-based family therapy model based on the data of the research is presented and illustrated with a clinical case. Algunos adolescentes consumidores de cannabis presentan una real adicción que esta frecuentemente acompañada de una serie de otras dificultades personales, familiares y sociales. Un modelo integrador de terapia familiar adaptada a esta problemática y basada en los datos de la investigación es presentada e ilustrada por un caso clínico.
Keywords: adolescent; cannabis; addiction; treatment and maintenance; family therapy; peer
|
Frei, A., Greiner, R. - A., Mehnert, A., & Dinkel, R. (1997). Sozioökonomische Bewertung der Versuche zur ärztlichen Verschreibung von Betäubungsmitteln : Schlussbericht. Basel: HealthEcon.
Keywords: government and politics; treatment and maintenance; outpatient care; drug substitution therapy; heroin-assisted treatment; economics; economic impact; trial study; Switzerland
|
Knüsel, R., Rey-Baeriswyl, M. - C., Reynaud, C., & Sallin, Y. (2002). L'intervenant/e social/e : essai de définition et enjeux pour la formation : description, évaluation et analyse combinée des types d'emploi, des compétences, des logiques d'embauche et des trajectoires professionnelles. Givisiez: Ecole supérieure de travail social de Fribourg (ESTS).
Keywords: social services
|
Götte, R., Hofmann-Göttig, J., Passerschröer, M., Klein, M., Schwehm, H., Gies, C., et al. (1996). Kinder Suchtkranker : Symposium am 27.02.1996. Mainz: Rheinland-Pfalz, Ministerium für Kultur, Jugend, Familie und Frauen.
Keywords: target group; child; adolescent; addiction; AOD dependence; chemical addiction
|
Annen-Ruf, M., Weder, U., Stocker, J., Gros, D., Ruch, P., Abt, U., et al. (1995). Seminar “Drogenprävention – Die Rolle von Familie und Gesellschaft” : Schlussbericht = Séminaire “Prévention des toxicomanies – le rôle des familles et de la société” : rapport final. Bern: Nationale Schweizerische UNESCO-Kommission; Bundesamt für Gesundheitswesen (BAG).
|
European Monitoring Centre for Drugs and Drug Addiction. (2002). Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing ‘near-death’ experiences. The risk-assessment exercise was carried out in 2000 in the framework of the Joint action on new synthetic drugs. In March 2001, the EU Justice and Home Affairs Council adopted formal conclusions that Member States should monitor this drug closely. This publication records the findings and conclusions of the exercise. Among others, it draws together the various elements used to assess the substance including: the final risk-assessment report; contributions from Europol and the European Agency for the Evaluation of Medicinal Products; a review of pharmacotoxicological data; epidemiological evidence on the associated public-health risks and sociological and criminological evidence.
Keywords: ketamine; monitoring; risk assessment; designer drug; research chemical; report; Europe
|